Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $20,255 | 10 | 47.0% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $17,690 | 2 | 41.1% |
| Travel and Lodging | $4,957 | 4 | 11.5% |
| Food and Beverage | $133.00 | 4 | 0.3% |
| Education | $28.96 | 2 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $43,064 | 22 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $18.09 | 1 | Merck Sharp & Dohme LLC ($18.09) |
| 2023 | $26,525 | 13 | Merck Sharp & Dohme LLC ($26,525) |
| 2022 | $7,015 | 2 | Merck Sharp & Dohme LLC ($7,015) |
| 2021 | $5,506 | 4 | Merck Sharp & Dohme Corporation ($5,506) |
| 2020 | $4,000 | 2 | Merck Sharp & Dohme Corporation ($4,000) |
All Payment Transactions
22 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | Merck Sharp & Dohme LLC | WELIREG (Drug) | Education | In-kind items and services | $18.09 | General |
| Category: ONCOLOGY | ||||||
| 11/29/2023 | Merck Sharp & Dohme LLC | — | Consulting Fee | Cash or cash equivalent | $3,050.00 | General |
| 10/30/2023 | Merck Sharp & Dohme LLC | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $13,420.00 | General |
| 10/30/2023 | Merck Sharp & Dohme LLC | — | Travel and Lodging | Cash or cash equivalent | $150.00 | General |
| 10/10/2023 | Merck Sharp & Dohme LLC | — | Food and Beverage | In-kind items and services | $47.00 | General |
| 10/10/2023 | Merck Sharp & Dohme LLC | — | Food and Beverage | In-kind items and services | $24.00 | General |
| 10/10/2023 | Merck Sharp & Dohme LLC | — | Food and Beverage | In-kind items and services | $15.00 | General |
| 10/09/2023 | Merck Sharp & Dohme LLC | — | Travel and Lodging | In-kind items and services | $4,238.03 | General |
| 10/09/2023 | Merck Sharp & Dohme LLC | — | Travel and Lodging | In-kind items and services | $405.00 | General |
| 10/09/2023 | Merck Sharp & Dohme LLC | — | Travel and Lodging | In-kind items and services | $164.16 | General |
| 10/09/2023 | Merck Sharp & Dohme LLC | — | Food and Beverage | In-kind items and services | $47.00 | General |
| 08/01/2023 | Merck Sharp & Dohme LLC | — | Consulting Fee | Cash or cash equivalent | $2,745.00 | General |
| 01/30/2023 | Merck Sharp & Dohme LLC | — | Consulting Fee | Cash or cash equivalent | $1,220.00 | General |
| 01/04/2023 | Merck Sharp & Dohme LLC | WELIREG (Drug) | Consulting Fee | Cash or cash equivalent | $1,000.00 | General |
| Category: ONCOLOGY | ||||||
| 10/12/2022 | Merck Sharp & Dohme LLC | — | Consulting Fee | Cash or cash equivalent | $2,745.00 | General |
| 10/05/2022 | Merck Sharp & Dohme LLC | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,270.00 | General |
| 12/15/2021 | Merck Sharp & Dohme Corporation | — | Consulting Fee | Cash or cash equivalent | $2,745.00 | General |
| 11/24/2021 | Merck Sharp & Dohme Corporation | WELIREG (Drug) | Consulting Fee | Cash or cash equivalent | $1,250.00 | General |
| Category: ONCOLOGY | ||||||
| 04/09/2021 | Merck Sharp & Dohme Corporation | KEYTRUDA (Biological) | Education | In-kind items and services | $10.87 | General |
| Category: ONCOLOGY | ||||||
| 04/05/2021 | Merck Sharp & Dohme Corporation | — | Consulting Fee | Cash or cash equivalent | $1,500.00 | General |
| 11/06/2020 | Merck Sharp & Dohme Corporation | MK-6482 (Drug) | Consulting Fee | Cash or cash equivalent | $2,500.00 | General |
| Category: ONCOLOGY | ||||||
| 10/09/2020 | Merck Sharp & Dohme Corporation | — | Consulting Fee | Cash or cash equivalent | $1,500.00 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 59 | 117 | $70,818 | $13,684 |
| 2022 | 3 | 61 | 130 | $64,146 | $13,041 |
| 2021 | 2 | 36 | 56 | $25,047 | $5,989 |
| 2020 | 5 | 123 | 228 | $107,952 | $23,659 |
All Medicare Procedures & Services
12 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 45 | 97 | $61,688 | $11,669 | 18.9% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 14 | 20 | $9,130 | $2,015 | 22.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 30 | 58 | $36,239 | $7,113 | 19.6% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 18 | 59 | $24,112 | $5,127 | 21.3% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2022 | 13 | 13 | $3,795 | $801.58 | 21.1% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Facility | 2021 | 18 | 35 | $18,210 | $4,360 | 23.9% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Facility | 2021 | 18 | 21 | $6,837 | $1,629 | 23.8% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 41 | 135 | $57,145 | $12,491 | 21.9% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 31 | 31 | $25,405 | $5,627 | 22.1% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2020 | 22 | 23 | $10,112 | $2,215 | 21.9% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Facility | 2020 | 13 | 23 | $11,828 | $2,200 | 18.6% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Facility | 2020 | 16 | 16 | $3,462 | $1,126 | 32.5% |
About Dr. Othon Iliopoulos, MD
Dr. Othon Iliopoulos, MD is a Medical Oncology healthcare provider based in Boston, Massachusetts. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/01/2006. The National Provider Identifier (NPI) number assigned to this provider is 1447352448.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Othon Iliopoulos, MD has received a total of $43,064 in payments from pharmaceutical and medical device companies, with $18.09 received in 2024. These payments were reported across 22 transactions from 1 company. The most common payment nature is "Consulting Fee" ($20,255).
As a Medicare-enrolled provider, Iliopoulos has provided services to 279 Medicare beneficiaries, totaling 531 services with total Medicare billing of $56,372. Data is available for 4 years (2020–2023), covering 12 distinct procedure/service records.
Practice Information
- Specialty Medical Oncology
- Location Boston, MA
- Active Since 09/01/2006
- Last Updated 12/18/2012
- Taxonomy Code 207RX0202X
- Entity Type Individual
- NPI Number 1447352448
Products in Payments
- MK-6482 (Drug) $2,500
- WELIREG (Drug) $2,268
- KEYTRUDA (Biological) $10.87
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Medical Oncology Doctors in Boston
Dr. George Demetri, Md, MD
Medical Oncology — Payments: $1.6M
Pasi Antero Janne, Md Phd, MD PHD
Medical Oncology — Payments: $1.1M
Dr. Praful Ravi, Mb Bchir, MB BCHIR
Medical Oncology — Payments: $921,658
Dr. Alicia Morgans, Md, MD
Medical Oncology — Payments: $755,277
Dr. Erica Mayer, Md Mph, MD MPH
Medical Oncology — Payments: $665,160
Dr. Joaquin Bellmunt Molins, M.d, M.D
Medical Oncology — Payments: $610,701